Showing results (31-40 of 5,037) with videos related to

Sort By:
Pageof 504
Multiple Sclerosis and Related Disorders|February 1, 2021
Effect of inosine monophosphate dehydrogenase-1 gene polymorphisms on mycophenolate mofetil effectiveness in neuromyelitis optica spectrum disorder patientsLanzhi Liu, Zhaohui Luo, Fan Liu, et al.
Multiple Sclerosis and Related Disorders|February 1, 2021
Lower lymphocyte counts and older age are associated with reduced multiple sclerosis disease activity during dimethyl fumarate treatmentRiccardo Garbo, Simone Lorenzut, Ilaria Del Negro, et al.
Multiple Sclerosis and Related Disorders|February 1, 2021
Cancer diagnosis in a Spanish cohort of multiple sclerosis patients under dimethylfumarate treatmentMayra Gómez-Moreno, Victoria Galán Sánchez-Seco, Sara Moreno-García, et al.
Multiple Sclerosis and Related Disorders|January 15, 2021
Seasonal patterns of relapse and disability in Danish MS patients: A population-based cohort studyHolly C Elser, Nils Koch-Henriksen, Melinda Magyari
Multiple Sclerosis and Related Disorders|January 28, 2021
Development of SARS-CoV-2 IgM and IgG antibodies in a relapsing multiple sclerosis patient on ofatumumabRamon E Flores-Gonzalez, Jeffrey Hernandez, Leticia Tornes, et al.
Multiple Sclerosis and Related Disorders|January 21, 2021
Use of a claims-based algorithm to estimate disease severity in the multiple sclerosis Medicare populationJoshua C Toliver, Jamie C Barner, Kenneth A Lawson, et al.
Multiple Sclerosis and Related Disorders|February 5, 2021
Self-reported use of vitamin D supplements is associated with higher physical quality of life scores in multiple sclerosisSteve Simpson-Yap, Pia Jelinek, Tracey Weiland, et al.
Multiple Sclerosis and Related Disorders|January 15, 2022
Comparison of SARS-CoV-2 antibody response after two doses of mRNA and inactivated vaccines in multiple sclerosis patients treated with disease-modifying therapiesSerkan Ozakbas, Cavid Baba, Yavuz Dogan, et al.
Multiple Sclerosis and Related Disorders|January 15, 2022
Real world comparison of teriflunomide and dimethyl fumarate in naïve relapsing multiple sclerosis patients: Evidence from the Italian MS registerAurora Zanghì, Carlo Avolio, Maria Pia Amato, et al.
Multiple Sclerosis and Related Disorders|January 15, 2022
Neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio are associated with a 2-year relapse in patients with multiple sclerosisWei-Chin Huang, Hui-Chen Lin, Yao-Hsu Yang, et al.
Pageof 504